Metanephric adenoma overview: Difference between revisions

Jump to navigation Jump to search
Shanshan Cen (talk | contribs)
No edit summary
Shanshan Cen (talk | contribs)
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
'''Metanephric adenoma''' (MA)is a rare, [[benign]] [[tumor]] of the [[kidney]].
'''Metanephric adenoma''' (MA)is a rare, [[benign]] [[tumor]] of the [[kidney]].
==Historical Perspective==
Metanephric adenoma was first described by Brisigotti, Cozzutto et al. in 1992.<ref name="pmid1333853">{{cite journal |vauthors=Brisigotti M, Cozzutto C, Fabbretti G, Sergi C, Callea F |title=Metanephric adenoma |journal=[[Histology and Histopathology]] |volume=7 |issue=4 |pages=689–92 |year=1992 |pmid=1333853 |doi= |url= |issn=}}</ref>
==Classification==
There is no classification system established for metanephric adenoma.
==Pathophysiology==
On gross pathology, a sharply circumscribed, nonencapsulated solitary [[mass]] is the characteristic finding of metanephric adenoma. On microscopic histopathological analysis, small uniform cells with fine [[chromatin]] and smooth [[nuclear membrane]], variable architecture, and [[Psammoma body|psammoma bodies]] are characteristic findings of metanephric adenoma.
==Causes==
Metanephric adenoma may be caused by the allelic changes of [[tumor suppressor gene]] on [[chromosome]] 2p13.
<ref name="pmid11172302">{{cite journal |vauthors=Pesti T, Sükösd F, Jones EC, Kovacs G |title=Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping |journal=[[Human Pathology]] |volume=32 |issue=1 |pages=101–4 |year=2001 |pmid=11172302 |doi=10.1053/hupa.2001.21132 |url=http://linkinghub.elsevier.com/retrieve/pii/S0046-8177(01)63640-2 |issn=}}</ref>


==References==
==References==

Revision as of 13:52, 10 November 2015

Metanephric adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metanephric adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Metanephric adenoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Metanephric adenoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Metanephric adenoma overview

CDC on Metanephric adenoma overview

Metanephric adenoma overview in the news

Blogs on Metanephric adenoma overview

Directions to Hospitals Treating Metanephric adenoma

Risk calculators and risk factors for Metanephric adenoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Metanephric adenoma (MA)is a rare, benign tumor of the kidney.

Historical Perspective

Metanephric adenoma was first described by Brisigotti, Cozzutto et al. in 1992.[1]

Classification

There is no classification system established for metanephric adenoma.

Pathophysiology

On gross pathology, a sharply circumscribed, nonencapsulated solitary mass is the characteristic finding of metanephric adenoma. On microscopic histopathological analysis, small uniform cells with fine chromatin and smooth nuclear membrane, variable architecture, and psammoma bodies are characteristic findings of metanephric adenoma.

Causes

Metanephric adenoma may be caused by the allelic changes of tumor suppressor gene on chromosome 2p13. [2]


References

  1. Brisigotti M, Cozzutto C, Fabbretti G, Sergi C, Callea F (1992). "Metanephric adenoma". Histology and Histopathology. 7 (4): 689–92. PMID 1333853.
  2. Pesti T, Sükösd F, Jones EC, Kovacs G (2001). "Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping". Human Pathology. 32 (1): 101–4. doi:10.1053/hupa.2001.21132. PMID 11172302.

Template:WH Template:WS